Centaurus Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,169
| Closed | -$177K | – | 798 |
|
|
2024
Q1 | $177K | Sell |
6,169
-334
| -5% | -$9.58K | 0.01% | 645 |
|
|
2023
Q4 | $213K | Sell |
6,503
-6
| -0.1% | -$197 | 0.02% | 576 |
|
|
2023
Q3 | $181K | Buy |
6,509
+20
| +0.3% | +$556 | 0.02% | 590 |
|
|
2023
Q2 | $221K | Sell |
6,489
-3,456
| -35% | -$118K | 0.02% | 545 |
|
|
2023
Q1 | $299K | Buy |
9,945
+1,209
| +14% | +$36.3K | 0.02% | 541 |
|
|
2022
Q4 | $247K | Buy |
8,736
+247
| +3% | +$6.98K | 0.02% | 552 |
|
|
2022
Q3 | $279K | Buy |
8,489
+339
| +4% | +$11.1K | 0.03% | 510 |
|
|
2022
Q2 | $257K | Sell |
8,150
-20
| -0.2% | -$631 | 0.03% | 532 |
|
|
2022
Q1 | $375K | Sell |
8,170
-177
| -2% | -$8.12K | 0.03% | 488 |
|
|
2021
Q4 | $511K | Buy |
8,347
+242
| +3% | +$14.8K | 0.04% | 430 |
|
|
2021
Q3 | $606K | Sell |
8,105
-31,108
| -79% | -$2.33M | 0.05% | 374 |
|
|
2021
Q2 | $3.63M | Buy |
39,213
+31,577
| +414% | +$2.92M | 0.31% | 79 |
|
|
2021
Q1 | $678K | Buy |
7,636
+1,096
| +17% | +$97.3K | 0.07% | 304 |
|
|
2020
Q4 | $610K | Buy |
6,540
+857
| +15% | +$79.9K | 0.06% | 324 |
|
|
2020
Q3 | $362K | Buy |
5,683
+3,458
| +155% | +$220K | 0.05% | 328 |
|
|
2020
Q2 | $116K | Buy |
+2,225
| New | +$116K | 0.02% | 554 |
|
|
2018
Q3 | – | Sell |
-120
| Closed | -$3K | – | 612 |
|
|
2018
Q2 | $3K | Buy |
+120
| New | +$3K | ﹤0.01% | 1907 |
|